A detailed history of Ameriprise Financial Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 392,273 shares of CORT stock, worth $19.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
392,273
Previous 353,121 11.09%
Holding current value
$19.8 Million
Previous $11.5 Million 58.18%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$29.51 - $46.26 $1.16 Million - $1.81 Million
39,152 Added 11.09%
392,273 $18.1 Million
Q2 2024

Aug 14, 2024

BUY
$22.21 - $34.48 $1.34 Million - $2.08 Million
60,221 Added 20.56%
353,121 $11.5 Million
Q1 2024

May 15, 2024

BUY
$21.1 - $27.46 $381,066 - $495,927
18,060 Added 6.57%
292,900 $7.38 Million
Q4 2023

Feb 14, 2024

SELL
$24.82 - $32.88 $532,662 - $705,637
-21,461 Reduced 7.24%
274,840 $8.93 Million
Q3 2023

Nov 14, 2023

SELL
$21.97 - $33.8 $573,636 - $882,517
-26,110 Reduced 8.1%
296,301 $8.07 Million
Q2 2023

Aug 14, 2023

SELL
$21.44 - $25.15 $865,468 - $1.02 Million
-40,367 Reduced 11.13%
322,411 $7.17 Million
Q1 2023

May 15, 2023

SELL
$19.2 - $24.47 $209,472 - $266,967
-10,910 Reduced 2.92%
362,778 $7.86 Million
Q4 2022

Feb 14, 2023

SELL
$19.95 - $29.96 $261,524 - $392,745
-13,109 Reduced 3.39%
373,688 $7.59 Million
Q3 2022

Nov 14, 2022

SELL
$24.7 - $29.12 $260,066 - $306,604
-10,529 Reduced 2.65%
386,797 $9.92 Million
Q2 2022

Aug 15, 2022

SELL
$17.33 - $25.3 $61,937 - $90,422
-3,574 Reduced 0.89%
397,326 $9.45 Million
Q1 2022

May 16, 2022

SELL
$16.53 - $25.21 $25,753 - $39,277
-1,558 Reduced 0.39%
400,900 $9.03 Million
Q4 2021

Feb 14, 2022

SELL
$17.1 - $23.34 $635,111 - $866,870
-37,141 Reduced 8.45%
402,458 $7.97 Million
Q3 2021

Nov 15, 2021

SELL
$19.68 - $22.53 $402,908 - $461,256
-20,473 Reduced 4.45%
439,599 $8.65 Million
Q2 2021

Aug 16, 2021

SELL
$19.97 - $24.43 $209,345 - $256,099
-10,483 Reduced 2.23%
460,072 $10.1 Million
Q1 2021

May 17, 2021

BUY
$23.49 - $30.56 $577,501 - $751,317
24,585 Added 5.51%
470,555 $11.2 Million
Q4 2020

Feb 12, 2021

SELL
$16.78 - $27.3 $262,506 - $427,081
-15,644 Reduced 3.39%
445,970 $11.7 Million
Q3 2020

Nov 16, 2020

SELL
$12.46 - $19.98 $266,295 - $427,012
-21,372 Reduced 4.42%
461,614 $8.04 Million
Q2 2020

Aug 14, 2020

SELL
$11.0 - $18.26 $199,683 - $331,473
-18,153 Reduced 3.62%
482,986 $8.12 Million
Q1 2020

May 15, 2020

SELL
$10.11 - $14.04 $267,409 - $371,358
-26,450 Reduced 5.01%
501,139 $5.96 Million
Q4 2019

Feb 14, 2020

SELL
$12.06 - $16.96 $189,173 - $266,034
-15,686 Reduced 2.89%
527,589 $6.38 Million
Q3 2019

Nov 14, 2019

SELL
$10.41 - $14.66 $595,868 - $839,138
-57,240 Reduced 9.53%
543,275 $7.68 Million
Q2 2019

Aug 14, 2019

SELL
$9.78 - $12.76 $152,577 - $199,068
-15,601 Reduced 2.53%
600,515 $6.7 Million
Q1 2019

May 15, 2019

SELL
$10.03 - $15.71 $130,500 - $204,402
-13,011 Reduced 2.07%
616,116 $7.23 Million
Q4 2018

Feb 14, 2019

SELL
$11.29 - $17.19 $31,781 - $48,389
-2,815 Reduced 0.45%
629,127 $8.41 Million
Q3 2018

Nov 14, 2018

BUY
$12.27 - $15.65 $830,752 - $1.06 Million
67,706 Added 12.0%
631,942 $8.86 Million
Q2 2018

Aug 14, 2018

SELL
$15.3 - $19.69 $4.38 Million - $5.64 Million
-286,267 Reduced 33.66%
564,236 $8.87 Million
Q1 2018

May 15, 2018

SELL
$14.59 - $25.5 $22,833 - $39,907
-1,565 Reduced 0.18%
850,503 $14 Million
Q4 2017

Feb 12, 2018

BUY
$15.77 - $20.72 $8.68 Million - $11.4 Million
550,373 Added 182.43%
852,068 $15.4 Million
Q3 2017

Nov 07, 2017

BUY
$12.3 - $19.3 $3.71 Million - $5.82 Million
301,695
301,695 $5.82 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.4B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.